generated: '2026-08-04'
method: derived
source:
- https://dalcorpharma.com/wp-json/wp/v2
- openapi/dalcor-pharmaceuticals-content-openapi.yml
- live probes 2026-08-04
note: >-
  DalCor publishes no API versioning policy, deprecation policy, SLA, status page or changelog — it
  runs no developer program. The lifecycle recorded here is that of the underlying WordPress REST
  namespace as deployed on dalcorpharma.com. Absences below are recorded facts, not omissions, and
  no StatusPage or Deprecation pointer is emitted in apis.yml because neither exists.
versioning:
  scheme: namespace-in-path
  current: wp/v2
  routes_published: 118
  routes_source: https://dalcorpharma.com/wp-json/wp/v2
  policy_url: null
  docs: https://developer.wordpress.org/rest-api/
  namespaces_observed: [wp/v2, oembed/1.0, wp-site-health/v1, yoast/v1, elementor/v1]
  namespace_discovery_note: >-
    The root index at /wp-json/ returns EMPTY `namespaces` and `routes` arrays on this deployment, so
    the namespace list above was established by probing each candidate directly rather than read off
    the index. Only wp/v2 and oembed/1.0 carry public content routes; yoast/v1, elementor/v1 and
    wp-site-health/v1 are plugin/administrative surfaces.
  note: >-
    A version change would arrive as a new namespace segment (wp/v3). Because the version is that of
    upstream WordPress rather than of DalCor, DalCor exercises no editorial control over the
    contract and gives no notice of change.
deprecation:
  policy_url: null
  sunset_header: false
  deprecation_header: false
  evidence: No Sunset or Deprecation response headers observed on any probed route.
deprecated_operations: []
sla:
  url: null
  uptime_target: null
status_page:
  url: null
  evidence: >-
    status.dalcorpharma.com does not resolve (dig, 2026-08-04) and no status page is linked from
    dalcorpharma.com. The site is fronted by Cloudflare and served by PHP 8.2 behind Plesk, whose own
    status pages are third-party infrastructure, not a DalCor commitment, so no StatusPage pointer is
    emitted.
changelog:
  api_changelog_url: null
  press_releases: https://dalcorpharma.com/press-releases/
  feed: https://dalcorpharma.com/feed/
  latest_post_observed: '2024-12-11'
  note: >-
    The company publishes dated press releases but no API changelog, so no changelog/ artifact and no
    ChangeLog pointer is emitted. The news stream is itself readable through this API via listPosts
    filtered on category 13. The most recent post observed on 2026-08-04 was dated 2024-12-11 — the
    content surface is low-velocity.
programme_milestones:
  note: >-
    Not an API lifecycle — recorded because it is the lifecycle that matters for this company and is
    stated on its own public pages.
  dal_gene_301: Completed. Primary composite endpoint not statistically significant (HR 0.88, p=0.12);
    21% relative risk reduction in fatal and non-fatal MI (HR 0.79, p=0.02) in 6,149 patients.
  dal_gene_2_302: >-
    Phase 3 confirmatory trial in 2,000 post-ACS patients with the ADCY9 AA genotype, coordinated by
    the Montreal Health Innovations Coordinating Centre. First patient expected Q3 2023, interim
    efficacy analysis in 2026, completion anticipated 2027 (as published on the company's
    Dal-GenE-2 trial page).
support:
  channel: https://dalcorpharma.com/contact-us/
  email: info@DalCorpharma.com
  offices:
  - {country: Canada, address: '2001 Boulevard Robert Bourassa, Suite 1700, Montreal, QC H3A 2A6', phone: '+1 514-508-5099'}
  - {country: Switzerland, address: 'Baarerstrasse 2, 6302 Zug', phone: '+41 41 727 67 89'}
  - {country: United Kingdom, address: 'Q3, the Square, Randalls Way, Leatherhead, KT22 7TW', phone: '+44 207-842-2275'}
  - {country: United States, address: '677 N. Washington Blvd., Suite 132, Sarasota, Florida 34236', phone: '+1 941-952-5843'}
  note: >-
    This is the corporate contact channel, not an API support channel. No developer support surface
    exists.
terms:
  terms_of_service: null
  evidence: '/terms and /terms-of-use/ both return 404; the site publishes a Privacy Policy but no terms of use.'
  privacy_policy: https://dalcorpharma.com/privacy-policy/